These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28095711)

  • 21. A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth.
    Yu SH; Maynard JP; Vaghasia AM; De Marzo AM; Drake CG; Sfanos KS
    Prostate; 2019 Feb; 79(2):215-222. PubMed ID: 30345534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.
    Martiniello-Wilks R; Dane A; Mortensen E; Jeyakumar G; Wang XY; Russell PJ
    Anticancer Res; 2003; 23(3B):2633-42. PubMed ID: 12894551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory Role of Surfactant Protein-D in a Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model.
    Ganguly K; Kishore U; Metkari SM; Madan T
    Front Immunol; 2022; 13():930449. PubMed ID: 35874783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
    Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
    J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model.
    Saleem M; Adhami VM; Ahmad N; Gupta S; Mukhtar H
    Clin Cancer Res; 2005 Jan; 11(1):147-53. PubMed ID: 15671539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nintedanib effects on delaying cancer progression and decreasing COX-2 and IL-17 in the prostate anterior lobe in TRAMP mice.
    Alves LF; da Silva RF; Cagnon VHA
    Tissue Cell; 2018 Feb; 50():96-103. PubMed ID: 29429524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
    Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
    Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.
    Venier NA; Yamamoto T; Sugar LM; Adomat H; Fleshner NE; Klotz LH; Venkateswaran V
    Prostate; 2015 Sep; 75(12):1300-11. PubMed ID: 26047020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
    Jeet V; Ow K; Doherty E; Curley B; Russell PJ; Khatri A
    Prostate; 2008 Apr; 68(5):548-62. PubMed ID: 18247402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.
    Suman S; Das TP; Moselhy J; Pal D; Kolluru V; Alatassi H; Ankem MK; Damodaran C
    Oncotarget; 2016 Aug; 7(33):53751-53761. PubMed ID: 27447565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice.
    Chang SN; Han J; Abdelkader TS; Kim TH; Lee JM; Song J; Kim KS; Park JH; Park JH
    Prostate; 2014 Sep; 74(13):1266-77. PubMed ID: 25053105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
    Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
    Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
    Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer.
    El-Kenawi A; Gatenbee C; Robertson-Tessi M; Bravo R; Dhillon J; Balagurunathan Y; Berglund A; Vishvakarma N; Ibrahim-Hashim A; Choi J; Luddy K; Gatenby R; Pilon-Thomas S; Anderson A; Ruffell B; Gillies R
    Br J Cancer; 2019 Oct; 121(7):556-566. PubMed ID: 31417189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest.
    Cho HJ; Lim DY; Kwon GT; Kim JH; Huang Z; Song H; Oh YS; Kang YH; Lee KW; Dong Z; Park JH
    Int J Mol Sci; 2016 Feb; 17(2):264. PubMed ID: 26907265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.